… The long-term effects of these medications on children’s physical and mental development
have … This study highlighted the mental health status of children in Alberta, and the extent of …

… for the Use of Atypical Antipsychotic Medication in Children and … For the current study, our
objective was to obtain a more … , better education of clinicians, and development of a uniform, …

… and adolescents' physical and psychological development, leading to possible lasting …
We reported the 20-year prescribing trends of all, typical, and atypical antipsychotics as annual …

… all active child and adolescent psychiatrists and developmental … by child and adolescent
psychiatrists, whereas children and … are typically treated by developmental pediatricians. We …

… ,” were developed in the 1950s; SGA, also known as “atypical antipsychotics,” … study revealed
that SGA monotherapy was the most frequent antipsychotic prescription pattern for children …

… The purpose of this study was to compare antipsychotic use … The 2018 Canadian consensus
guidelines for the primary care … Atypical antipsychotics for disruptive behaviour disorders in …

… the observed period: developmental disorders of learning or … Main findings of this study
are: 1) majority of the patients … label use of atypical antipsychotics in children and adolescents …

… In this study, antipsychotics prescribed by pediatric psychiatric … development and improvement
of follow-up guidelines. In … the use of atypical antipsychotic medications in children and …

… In GXR users, the increase in prescription drug cost after 6 … AAPs than GXR, owing to more
psychiatric department visits. … this study, a follow-up to the antecedent Canadian RAMQ study …

… and receipt of a prescription from a child and adolescent psychiatrist or … and adolescent
psychiatrist or developmental pediatrician … Finally, our study was conducted in a single Canadian …